Suppr超能文献

非标准化高强度透析剂量可提高终末期肾病患者的生存率。

Nonstandardized High-Intensity Dialysis Dose Improves Survival in Patients With End-Stage Renal Disease.

作者信息

Nenova Diana D, Yankov Yanko G, Chausheva Gergana M

机构信息

Clinic of Nephrology and Dialysis, University Hospital St. Marina, Varna, BGR.

Department of Internal Disease, Medical University "Prof. Dr. Paraskev Stoyanov", Varna, BGR.

出版信息

Cureus. 2024 Oct 17;16(10):e71725. doi: 10.7759/cureus.71725. eCollection 2024 Oct.

Abstract

Introduction One of the most important critical determinants of quality of life and adequacy of hemodialysis (HD) performed in patients is the recorded survival and mortality rates. Nowadays, as an adequately performed HD dialysis, we accept the one with reaching values for the index single pool Kt/V (spKt/V) higher than 1.2. In recent years, more intensive HD regimens with spKt/V≥1.5 have been increasingly discussed, which can significantly improve patient survival. However, their benefit has yet to be proven, as extremely high spKt/V values can be misleading as they may result from malnutrition leading to reduced survival and increased relative risk of death. The aim of this study is to present to the community the impact of nonstandardized high dialysis doses (spKt/V>1.5) on annual survival and mortality rates in the dialysis population and to explore new strategies for enhancing quality of life and survival, as well as to promote their regular implementation in clinical practice and personalized patient care. Material and methods The present retrospective study was conducted at the Clinic of Nephrology and Dialysis at University Hospital St. Marina in Varna, Bulgaria for a period of five years. It involved a survival analysis of 100 dialysis patients who met the inclusion and exclusion criteria. The dialysis dose delivered was the criterion for their allocation into three studied groups: Group 1 with adequate dose (standardized) - spKt/V = 1.2-1.49, Group 2 with high dose (nonstandardized) - spKt/V≥1.5, and Group 3 with inadequate dose (low) - spKt/V≤1.19. We recorded total annual mortality and survival rates, analyzing their relationship with the delivered dialysis dose and assessing the relative risk of death and expected survival. Results The analysis results indicated that high-intensity regimens with an spKt/V≥1.5 were linked to a better patient prognosis, with a significantly lower risk of death compared to standard regimens and increased survival expectancy. Data from the survival analysis suggested that the long-term impact of increasing the dialysis dose (spKt/V≥1.5) on survival becomes evident after the third year. Additionally, nutritional status parameters emerged as key risk factors for deterioration, along with the indicators of dialysis adequacy. Discussion Improved survival rates have been observed in patients undergoing nocturnal HD. In the latter, significantly higher spKt/V values have been achieved due to extended dialysis sessions, as well as in those performing dialysis at home. Despite concerns about possible misinterpretation of extremely high spKt/V values (>1.5) as a sign of malnutrition when urea volume of distribution is reduced, it is found that when only urea clearance (Kt) is used, without volume counts, the risk of death decreases by 2% for each liter increase in clearance. This demonstrates that the assessment of dialysis adequacy is a much broader concept than the values of generally accepted indicators and should be focused on individualized care and risk assessment tailored to each patient. Conclusions We believe that the modern nephrological community should strive to achieve a high dialysis dose (spKt/V≥1.5) to improve clinical outcomes and patient prognosis. Assessing dialysis adequacy is complex and goes beyond a simple numerical value such as spKt/V. It requires careful monitoring of nutritional status and the management of all HD-related complications.

摘要

引言

患者进行血液透析(HD)时,生活质量和透析充分性的最重要关键决定因素之一是记录的生存率和死亡率。如今,作为充分进行的HD透析,我们认可单次尿素清除率(spKt/V)指标值高于1.2的透析。近年来,越来越多地讨论了spKt/V≥1.5的更强化HD方案,这可显著提高患者生存率。然而,其益处尚未得到证实,因为极高的spKt/V值可能会产生误导,因为它们可能是由营养不良导致的,从而导致生存率降低和死亡相对风险增加。本研究的目的是向社区展示非标准化高透析剂量(spKt/V>1.5)对透析人群年生存率和死亡率的影响,并探索提高生活质量和生存率的新策略,以及促进其在临床实践和个性化患者护理中的常规实施。

材料和方法

本回顾性研究在保加利亚瓦尔纳圣玛丽娜大学医院肾病与透析诊所进行,为期五年。对100名符合纳入和排除标准的透析患者进行了生存分析。所给予的透析剂量是将他们分配到三个研究组的标准:第1组为适当剂量(标准化)——spKt/V = 1.2 - 1.49,第2组为高剂量(非标准化)——spKt/V≥1.5,第3组为不适当剂量(低剂量)——spKt/V≤1.19。我们记录了年总死亡率和生存率,分析它们与所给予透析剂量的关系,并评估死亡相对风险和预期生存率。

结果

分析结果表明,spKt/V≥1.5的高强度方案与更好的患者预后相关,与标准方案相比死亡风险显著降低,生存预期增加。生存分析数据表明,增加透析剂量(spKt/V≥1.5)对生存的长期影响在第三年后变得明显。此外,营养状况参数以及透析充分性指标成为恶化的关键风险因素。

讨论

夜间HD患者的生存率有所提高。在后者中,由于透析时间延长以及在家中进行透析,已实现显著更高的spKt/V值。尽管有人担心当尿素分布容积减少时,极高的spKt/V值(>1.5)可能被误解为营养不良的迹象,但发现当仅使用尿素清除率(Kt)而不进行容积计数时,清除率每增加1升,死亡风险降低2%。这表明透析充分性的评估是一个比普遍接受指标的值更广泛的概念,应专注于针对每个患者的个性化护理和风险评估。

结论

我们认为,现代肾脏病学界应努力实现高透析剂量(spKt/V≥1.5)以改善临床结果和患者预后。评估透析充分性很复杂,不仅仅是一个简单的数值,如spKt/V。它需要仔细监测营养状况并管理所有与HD相关的并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1826/11568871/d9059de24ece/cureus-0016-00000071725-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验